CVS Health and The Midlife Collective Announce Research on Women’s Midlife Health and Reinvention

On October 15, 2026, CVS Health published an announcement of a collaboration with The Midlife Collective to study women’s physical, emotional and social experiences in midlife. The partners say the research will also examine identity and wider life circumstances, with findings intended to inform a documentary in development.

Why the project looks beyond symptoms

CVS Health women’s-health chief medical officer Dr. Joanne Armstrong described midlife conversations as having focused too heavily on symptoms and limitations. She presented the collaboration as an effort to bring clinical research together with storytelling and give women’s voices more space.

The narrower approach being challenged is a symptom-and-limitation account of midlife. The announcement challenges that framing rather than identifying a medical standard that should be replaced. Its proposed shift is to ask about the person experiencing midlife, not only the health concerns that may accompany it.

That distinction leaves room for both perspectives. Menopause-related concerns remain part of the announced research agenda. Identity and the circumstances of women’s lives are being placed alongside them rather than outside the conversation.

How to read the planned research

The partners describe a study spanning health and several connected areas of life. These are the subjects they intend to examine, rather than reported findings. The value of the proposed breadth lies in the questions it makes room for:

• Physical, emotional and social experiences. The announced scope brings these dimensions into the same research agenda. The useful editorial distinction is that a woman’s account of midlife need not be organised around a symptom list alone. Her wider experience is part of what the partners say they want to understand.
• Identity. The planned work includes how women experience their sense of self during this stage. That gives identity a place in the discussion without requiring it to become a diagnosis. For readers thinking about confidence and personal change, the relevant question is what matters to them beyond a medical description of transition.
• Caregiving. The partners include caregiving among the subjects they plan to study. Its inclusion makes responsibilities toward other people part of the proposed account of midlife. The meaningful point is recognition: those responsibilities belong within the conversation rather than being treated as background that research can simply set aside.
• Relationships. Relationships are another stated part of the agenda. This widens the proposed conversation beyond an individual woman’s physical experience. It also creates room to discuss connection in its own terms, without assuming that a relationship question must have a hormonal explanation or that a health intervention is necessarily its answer.
• Career transitions. The research is intended to address changes in working life. Including career transitions allows questions about direction and professional identity to sit beside questions about health. The editorial opportunity is to acknowledge work as part of a woman’s life without turning every career decision into a medical issue.
• Financial wellbeing. Finances are explicitly within the announced scope. That matters to the framing of the project because it places material circumstances beside personal experience. A broader account of midlife should leave space for financial questions on their own terms rather than translating them into the language of symptoms or individual attitude.
• Personal fulfilment. The partners also intend to examine fulfilment. This creates room for women’s priorities and aspirations alongside their concerns. It need not imply that everyone wants a dramatic new chapter. A useful reading of this topic leaves the meaning of fulfilment with the woman herself rather than setting a new expectation for her.

Together, these subjects describe a research agenda with a wider lens. They also offer a way to talk about reinvention without making it compulsory: personal change can be a subject worth understanding rather than another achievement women are expected to deliver.

Why a documentary is part of the announcement

The partners say the findings will help inform Her Second Act, a documentary in development by The Midlife Collective. TheWrap reported that the project is intended to challenge cultural narratives about women and aging. The announcement describes a film combining women’s stories with interviews, science and expert perspectives.

It names Abby Epstein and Constance Zimmer as co-directors, with Julie Flakstad as producer. Zimmer is also a co-founder of The Midlife Collective. She described the project’s intention as pairing storytelling with research while conveying both the complexity and the possibility of midlife.

That connection explains why this announcement belongs in a conversation about identity rather than only in a discussion of medical research. The project is intended to shape a public story about women’s lives. An appropriate editorial standard is to give personal accounts their full weight while keeping them distinct from conclusions drawn through research.

The strongest version of that relationship would allow each to do a different job. Stories could communicate individual experience, while the research would need to establish which conclusions its evidence supports. Neither needs to stand in for the other.

How to judge the evidence at this stage

This is an announced research collaboration, not a published study. The reviewed sources do not specify a sample size or recruitment method. They also do not provide research instruments, fieldwork dates or an analysis plan. No publication timetable is given.

There are no reported findings demonstrating improved health outcomes or changes in clinical practice. The announcement also does not establish that the research will represent the experiences of all women in midlife. Statements from the partners describe their intentions rather than an independent assessment of the design.

Those are the evidence boundaries for reading the announcement. When results become available, the useful questions will concern who participated and how the work was conducted. The reach of any conclusion should match the evidence behind it, whether that conclusion appears in a research publication or alongside a compelling film narrative.

How to keep health and reinvention in the same conversation

For readers, the useful shift is not to add more tasks to an already full life. It is to allow more than one kind of question into the conversation. A concern about physical health can sit beside a question about identity without requiring one to explain the other.

The announced topics offer language for that distinction. Health, relationships and fulfilment are all within the proposed scope. They do not need to be collapsed into a single story about hormones. Nor does recognising the wider picture require treating menopause-related concerns as less worthy of attention.

The same approach can inform a broader view of midlife progress. In this context, progress need not mean a public transformation or a newly defined identity. A more useful editorial question is whether the account of midlife leaves room for what the individual woman values.

Reinvention is best treated here as a possibility rather than a prescription. The title Her Second Act suggests a narrative of change, but readers do not have to organise their own lives around that narrative. Continuity and a different set of priorities deserve room in the discussion too.

Where a physical or emotional concern calls for individual assessment, a qualified healthcare professional is the appropriate person to discuss it with. Questions about work or relationships deserve attention on their own terms. A corporate research announcement should not become a shortcut to a personal medical conclusion.

For now, the most useful response is to take the broader questions seriously while keeping their status clear. The partners have identified subjects they want to investigate. Readers can recognise the relevance of those subjects without accepting a predetermined explanation for their own experiences.

Why this could matter for future care

If its eventual findings support the approach, this project could give clinicians a stronger basis for discussing identity and life circumstances alongside menopause-related concerns.

How Refemina helps

A midlife research agenda loses something when reinvention becomes another standard women are expected to meet; Refemina’s approach gives personal change space alongside health. Its evidence-led editorial work addresses uncertainty about identity and confidence during hormonal transition, helping readers understand this stage without a demand to become younger or turn every concern into a treatment opportunity.

Explore Resources

Sources

1. investors.cvshealth.com
2. CVS Health Partners With The Midlife Collective for Women's Study and Documentary